Search by Drug Name or NDC
NDC 43598-0181-11 REZIPRES 47 mg/10mL Details
REZIPRES 47 mg/10mL
REZIPRES is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Inc. The primary component is EPHEDRINE HYDROCHLORIDE.
Product Information
| NDC | 43598-0181 |
|---|---|
| Product ID | 43598-181_39988d93-955e-b4a2-40b5-d1678cf5aaf0 |
| Associated GPIs | |
| GCN Sequence Number | 085588 |
| GCN Sequence Number Description | ephedrine HCl VIAL 47 MG/10ML INTRAVEN |
| HIC3 | J5E |
| HIC3 Description | SYMPATHOMIMETIC AGENTS |
| GCN | 55102 |
| HICL Sequence Number | 002083 |
| HICL Sequence Number Description | EPHEDRINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | REZIPRES |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ephedrine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 47 |
| Active Ingredient Units | mg/10mL |
| Substance Name | EPHEDRINE HYDROCHLORIDE |
| Labeler Name | Dr. Reddy's Laboratories Inc |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA213536 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43598-0181-11 (43598018111)
| NDC Package Code | 43598-181-11 |
|---|---|
| Billing NDC | 43598018111 |
| Package | 10 mL in 1 VIAL, SINGLE-DOSE (43598-181-11) |
| Marketing Start Date | 2023-12-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |